Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Avantor, Inc.AVTR · Entity 3546 | EVP, Bioscience & Medtech | February 23, 2026 | February 25, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Avantor, Inc.
Report date February 23, 2026 · Filed February 25, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 362,859 |
Reported balance
After 2026-02-23 transaction · row 1
1 source rowRow 1 · 2026-02-23 · Tax withholding · Disposed 3,029 · Balance 362,859 F1: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 23, 2026 Filed Feb 25, 2026 22:27 UTC | Avantor, Inc. AVTR · Entity 3546 | Tax withholdingCommon Stock | 3,029 | $8.89 | $26,927.81 |
DisclosureSEC source: 0001628280-26-011809 · wk-form4_1772058466.xml · nonDerivative · entry 1 Gourdier Benoit · CIK 0001995333 · EVP, Bioscience & Medtech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 362,859 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 01:53 UTC | Avantor, Inc. AVTR · Entity 3546 | Tax withholdingCommon Stock | 4,160 | $9.03 | $37,564.80 |
DisclosureSEC source: 0001628280-26-010826 · wk-form4_1771897995.xml · nonDerivative · entry 2 Gourdier Benoit · CIK 0001995333 · EVP, Bioscience & Medtech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 365,888 F2 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| February 19, 2026 Filed Feb 24, 2026 01:53 UTC | Avantor, Inc. AVTR · Entity 3546 | GrantStock Options (Right to Buy) · Derivative | 528,848 | $0.00 Strike: $11.05 | $0.00 |
DisclosureSEC source: 0001628280-26-010826 · wk-form4_1771897995.xml · derivative · entry 3 Gourdier Benoit · CIK 0001995333 · EVP, Bioscience & Medtech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 528,848 Underlying: Common Stock · 528,848 shares Expires 2036-02-19 F3 · derivative.exercise_date: Reflects a grant of stock options that vest in three equal annual installments beginning on February 19, 2027. Read SEC document |
| February 19, 2026 Filed Feb 24, 2026 01:53 UTC | Avantor, Inc. AVTR · Entity 3546 | GrantCommon Stock | 134,364 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-010826 · wk-form4_1771897995.xml · nonDerivative · entry 1 Gourdier Benoit · CIK 0001995333 · EVP, Bioscience & Medtech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 370,048 F1 · kind: Reflects a grant of restricted stock units that vest in three equal annual installments beginning on February 19, 2027. Read SEC document |
| October 02, 2025 Filed Oct 3, 2025 20:28 UTC | Avantor, Inc. AVTR · Entity 3546 | Tax withholdingCommon Stock | 1,264 | $13.77 | $17,405.28 |
DisclosureSEC source: 0001628280-25-044081 · wk-form4_1759523311.xml · nonDerivative · entry 1 Gourdier Benoit · CIK 0001995333 · EVP, Bioscience Production 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 235,684 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| May 09, 2025 Filed May 12, 2025 21:32 UTC | Avantor, Inc. AVTR · Entity 3546 | GrantCommon Stock | 162,866 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-25-000144 · wk-form4_1747085567.xml · nonDerivative · entry 1 Gourdier Benoit · CIK 0001995333 · EVP, Bioscience Production 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 236,948 F1 · kind: Reflects a grant of restricted stock units that vest on May 9, 2027. Read SEC document |
| February 23, 2025 Filed Feb 24, 2025 22:31 UTC | Avantor, Inc. AVTR · Entity 3546 | Tax withholdingCommon Stock | 2,842 | $17.30 | $49,166.60 |
DisclosureSEC source: 0001722482-25-000040 · wk-form4_1740436267.xml · nonDerivative · entry 2 Gourdier Benoit · CIK 0001995333 · EVP, Bioscience Production 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,082 F2 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 22:31 UTC | Avantor, Inc. AVTR · Entity 3546 | GrantStock Options (Right to Buy) · Derivative | 86,565 | $0.00 Strike: $17.49 | $0.00 |
DisclosureSEC source: 0001722482-25-000040 · wk-form4_1740436267.xml · derivative · entry 3 Gourdier Benoit · CIK 0001995333 · EVP, Bioscience Production 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,565 Underlying: Common Stock · 86,565 shares Expires 2035-02-20 F3 · derivative.exercise_date: Reflects a grant of stock options that vest in three equal annual installments beginning on February, 20, 2026. Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 22:31 UTC | Avantor, Inc. AVTR · Entity 3546 | GrantCommon Stock | 35,734 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-25-000040 · wk-form4_1740436267.xml · nonDerivative · entry 1 Gourdier Benoit · CIK 0001995333 · EVP, Bioscience Production 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,924 F1 · kind: Reflects a grant of restricted stock units that vest in three equal annual installments beginning on February 20, 2026. Read SEC document |
| October 02, 2024 Filed Oct 4, 2024 21:00 UTC | Avantor, Inc. AVTR · Entity 3546 | Tax withholdingCommon Stock | 1,263 | $25.54 | $32,257.02 |
DisclosureSEC source: 0001722482-24-000156 · wk-form4_1728075601.xml · nonDerivative · entry 1 Gourdier Benoit · CIK 0001995333 · EVP, Bioscience Production 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,190 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 22:02 UTC | Avantor, Inc. AVTR · Entity 3546 | GrantStock Options (Right to Buy) · Derivative | 62,753 | $0.00 Strike: $24.35 | $0.00 |
DisclosureSEC source: 0001722482-24-000060 · wk-form4_1709071310.xml · derivative · entry 2 Gourdier Benoit · CIK 0001995333 · EVP, Biopharma Production 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,753 Underlying: Common Stock · 62,753 shares Expires 2034-02-23 F2 · derivative.exercise_date: Reflects a grant of stock options that vest in three equal annual installments beginning on February, 23, 2025. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 22:02 UTC | Avantor, Inc. AVTR · Entity 3546 | GrantCommon Stock | 25,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-24-000060 · wk-form4_1709071310.xml · nonDerivative · entry 1 Gourdier Benoit · CIK 0001995333 · EVP, Biopharma Production 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,453 F1 · kind: Reflects a grant of restricted stock units that vest in three equal annual installments beginning on February 23, 2025. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 20:40 UTC | Avantor, Inc. AVTR · Entity 3546 | GrantStock Options (Right to Buy) · Derivative | 39,281 | $0.00 Strike: $20.85 | $0.00 |
DisclosureSEC source: 0001722482-23-000186 · wk-form4_1696452011.xml · derivative · entry 2 Gourdier Benoit · CIK 0001995333 · EVP, Biopharma Production 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,281 Underlying: Common Stock · 39,281 shares Expires 2033-10-02 F2 · derivative.exercise_date: Reflects a grant of stock options that vest in four equal annual installments beginning on October 2, 2024. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 20:40 UTC | Avantor, Inc. AVTR · Entity 3546 | GrantCommon Stock | 16,786 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-23-000186 · wk-form4_1696452011.xml · nonDerivative · entry 1 Gourdier Benoit · CIK 0001995333 · EVP, Biopharma Production 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,786 F1 · kind: Reflects a grant of 16,786 restricted stock units that vest in four equal annual installments beginning on October 2, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.